CClinicalTrials.gg
Status unknownNCT01310907Updated Mar 9, 2011

Identify the Genes Polymorphisms Related to Non-familial Bradyarrhythmia

An observational study in Bradyarrhythmia, sponsored by China Medical University Hospital. Status unknown at 2 sites in Taiwan. Per ClinicalTrials.gov, last updated 2011-03-09.

Sponsored by China Medical University Hospital · Observational

The sponsor has not verified this record recently (last verified Mar 2011), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Enrollment
400
Sex
All
01

Study summary

Bradyarrhythmia, including sinus node dysfunction and atrioventricular block, is a major cause necessitating pacemaker implantation. In contrast to familial bradyarrhythmia known as by mutations at particular ion channels, limited information is available for the mechanistic study in non-familial bradyarrhythmia.

Possible gene polymorphisms related to non-familial bradyarrhythmia were studied. Comparison of multi-locus analysis and single-locus analysis will be analyzed between the cases and controls. Functional studies will perform to clarify the results of association study.

02

Conditions studied

  • Bradyarrhythmia

Browse trials for

03

In context

Bradycardia

306 studies on the registry are indexed under Bradycardia; 69 are open to participants now.

This study's planned enrollment of 400 is above the median of 257 across 129 observational studies indexed under Bradycardia.

Browse Bradycardia studies →

Lead sponsor

China Medical University Hospital is the lead sponsor of 464 studies on the registry; 116 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

The case group include 200 patients and the control group include 200 patients.

Inclusion criteria

  • The patients with non-familial bradyarrhythmia

Exclusion criteria

Exclusion Criteria:

  • Familial bradyarrhythmia Reversible bradyarrhythmia Bradyarrhythmia after open heart surgery and severe organic heart diseases
05

Study design

Enrollment
400 participants (estimated)

Groups and cohorts

  • sinus node dysfunction
  • Atrioventricular block
  • control
06

Study locations

2 of 2 sites recruiting
  • China Medical University Hospital
    Taichung, 404, Taiwan
    • Jan-Yow Chen, MD · Contact · janyow@ms77.hinet.net · +88622052121
    • Jan-Yow Chen, MD · Principal investigator
    Recruiting
  • China Medical University Hospital
    Taichung, 404, Taiwan
    • Jan-Yow Chen, MD · Contact · janyow@ms77.hinet.net · +886-4-22052121
    • Jan-Yow Chen, MD · Principal investigator
    Recruiting
07

References and documents

Publications

  • Mangrum JM, DiMarco JP. The evaluation and management of bradycardia. N Engl J Med. 2000 Mar 9;342(10):703-9. doi: 10.1056/NEJM200003093421006. No abstract available. PubMed 10706901 ↗
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 9, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01310907
Lead sponsor
China Medical University Hospital
Collaborators
China Medical University, China
First posted
Mar 9, 2011
Start date
Feb 2011
Last update
Mar 9, 2011

Study contacts

Jan-Yow Chen, MD
Contact
janyow@ms77.hinet.net
+422052121 ext. 2311
Jan-Yow Chen, MD
principal investigator · China Medical University Hospital
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion